These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 12869391)

  • 41. Trimetazidine in conditions other than coronary disease, old drug, new tricks?
    Zou H; Zhu XX; Ding YH; Jin QY; Qian LY; Huang DS; Cen XJ
    Int J Cardiol; 2017 May; 234():1-6. PubMed ID: 28256321
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trimetazidine inhibits cardiomyocyte apoptosis in a rabbit model of ischemia-reperfusion.
    Ruixing Y; Wenwu L; Al-Ghazali R
    Transl Res; 2007 Mar; 149(3):152-60. PubMed ID: 17320801
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolism of 4-pentenoic acid and inhibition of thiolase by metabolites of 4-pentenoic acid.
    Schulz H
    Biochemistry; 1983 Apr; 22(8):1827-32. PubMed ID: 6133549
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute effect of antidiabetic 1,4-dihydropyridine compound cerebrocrast on cardiac function and glucose metabolism in the isolated, perfused normal rat heart.
    Briede J; Stivrina M; Vigante B; Stoldere D; Duburs G
    Cell Biochem Funct; 2008; 26(2):238-45. PubMed ID: 17990288
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy.
    Tuunanen H; Engblom E; Naum A; Någren K; Scheinin M; Hesse B; Juhani Airaksinen KE; Nuutila P; Iozzo P; Ukkonen H; Opie LH; Knuuti J
    Circulation; 2008 Sep; 118(12):1250-8. PubMed ID: 18765391
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Direct toxic effects of aqueous extract of cigarette smoke on cardiac myocytes at clinically relevant concentrations.
    Yamada S; Zhang XQ; Kadono T; Matsuoka N; Rollins D; Badger T; Rodesch CK; Barry WH
    Toxicol Appl Pharmacol; 2009 Apr; 236(1):71-7. PubMed ID: 19371621
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical benefits of a metabolic approach in the management of coronary patients.
    Marzilli M
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V25-30. PubMed ID: 11206100
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolic modulation: a new therapeutic target in treatment of heart failure.
    Palaniswamy C; Mellana WM; Selvaraj DR; Mohan D
    Am J Ther; 2011 Nov; 18(6):e197-201. PubMed ID: 20393344
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fenofibrate modulates cardiac and hepatic metabolism and increases ischemic tolerance in diet-induced obese mice.
    Aasum E; Khalid AM; Gudbrandsen OA; How OJ; Berge RK; Larsen TS
    J Mol Cell Cardiol; 2008 Jan; 44(1):201-9. PubMed ID: 17931655
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolic agents in the management of diabetic coronary patients: a new era.
    Marazzi G; Volterrani M; Rosano GM
    Int J Cardiol; 2008 Jun; 127(1):124-5. PubMed ID: 18199501
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fatty acid oxidation in rat brain is limited by the low activity of 3-ketoacyl-coenzyme A thiolase.
    Yang SY; He XY; Schulz H
    J Biol Chem; 1987 Sep; 262(27):13027-32. PubMed ID: 3654601
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of fatty acid oxidation in heart.
    Schulz H
    J Nutr; 1994 Feb; 124(2):165-71. PubMed ID: 8308565
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure.
    Fragasso G; Palloshi A; Puccetti P; Silipigni C; Rossodivita A; Pala M; Calori G; Alfieri O; Margonato A
    J Am Coll Cardiol; 2006 Sep; 48(5):992-8. PubMed ID: 16949492
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trimetazidine improves recovery during reperfusion in isolated rat hearts after prolonged ischemia.
    Ikizler M; Dernek S; Sevin B; Kural T
    Anadolu Kardiyol Derg; 2003 Dec; 3(4):303-8. PubMed ID: 14675878
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of trimetazidine in management of ischemic cardiomyopathy.
    Bertomeu-Gonzalez V; Bouzas-Mosquera A; Kaski JC
    Am J Cardiol; 2006 Sep; 98(5A):19J-24J. PubMed ID: 16931202
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ["Persistent" angina: rationale for a metabolic approach].
    Marzilli M
    Ital Heart J; 2004 Mar; 5 Suppl 2():37S-41S. PubMed ID: 15074776
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mitochondrial changes induced by trimetazidine in the myocardium.
    Morillas Blasco PJ; Hernándiz Martinez A; Azorín Villena I; Portolés Sanz M; Pallarés Carratala V; Martinez VB; Capdevilla Carbonell C; Aguilar Llopis A; Cosín Aguilar J
    Med Sci Monit; 2005 Jun; 11(6):BR162-167. PubMed ID: 15917710
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
    Ferrari R; Merli E; Cicchitelli G; Mele D; Fucili A; Ceconi C
    Ann N Y Acad Sci; 2004 Nov; 1033():79-91. PubMed ID: 15591005
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin addition after ischemia improves recovery of function equal to ischemic preconditioning in rat heart.
    Fischer-Rasokat U; Beyersdorf F; Doenst T
    Basic Res Cardiol; 2003 Sep; 98(5):329-36. PubMed ID: 12955406
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preconditioning improves postischemic mitochondrial function and diminishes oxidation of mitochondrial proteins.
    Khaliulin I; Schwalb H; Wang P; Houminer E; Grinberg L; Katzeff H; Borman JB; Powell SR
    Free Radic Biol Med; 2004 Jul; 37(1):1-9. PubMed ID: 15183190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.